45.81 USD
↗ 0.00 (0.00%)AT CLOSE (03:59 PM EDT)
Veracyte, Inc.
VCYTNASDAQ • USD
45.86
↗ 0.04 (0.10%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
45.86
↗ 0.04 (0.10%)
Market: CLOSED
Veracyte, Inc. (VCYT) is currently trading at $45.83. Technical and fundamental signals align bullish — technicals rate "Strong Buy" while fundamentals indicate "Buy". This is driven by a robust Altman Z-Score and a bullish Golden Cross on the moving averages. On valuation, VCYT trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Oct 2, 2026.
Open?$44.94
High?$46.09
Low?$44.41
Prev. Close?$45.81
Volume?1.0M
Avg. Volume?1.4M
VWAP?$45.63
Rel. Volume?0.73x
Bid / Ask
Bid?$45.48 × 100
Ask?$48.27 × 100
Spread?$2.79
Midpoint?$46.88
Valuation & Ratios
Market Cap?3.7B
Shares Out?80.4M
Float?79.9M
Float %?99.4%
P/E Ratio?32.17
P/B Ratio?2.65
EPS?$1.42
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
Themes
Employees
755
Market Cap
3.7B
Industry
SERVICES-MEDICAL LABORATORIES
Website
Listed
2013-10-30
Address
6000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO, CA 94080
Phone: (650) 243-6300
SOUTH SAN FRANCISCO, CA 94080
Phone: (650) 243-6300
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?100
Momentum?75
Short Sent.?34
Piotroski F-Score?5/9Mixed
Altman Z-Score?41.50Safe
Confidence?60%Moderate
Short InterestHigh
Short % of Float?10.52%High
Short Interest?8.4M
Days to Cover?7.8
Free Float79.9M
Avg Daily Volume1.1M
Settlement Date2026-09-15
Financial Health
Current Ratio?9.16Strong
Quick Ratio?8.80Strong
Cash Ratio?4.77Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score56/100
P/E?32.2PRICEY▾
Peers100
S&P28
P/B?2.65CHEAP▾
Peers100
S&P61
P/S?6.55FAIR▾
Peers100
S&P19
P/FCF?22.2FAIR▾
Peers100
S&P48
EV/EBITDA?26.7HIGH▾
Peers100
S&P14
EV/Sales?6.02HIGH▾
Peers100
S&P28
Returns & Efficiency
ROE?8.3%FAIR▾
Peers50
S&P26
ROA?7.7%STRONG▾
Peers50
S&P64
Cash Flow & Enterprise
FCF?$166.0M
Enterprise Value?$3.4B
Fundamentals ratios updated end of day